P1661 - POLATUZUMAB VEDOTINA [140 MG PÓ CONC SOL INJ FRS]
TED · 742264-2026Award noticeawardedNo deadline given
Value
Estimated€106,759 · 106,758.63 EUR
Awarded—
WinnerROCHE Farmacêutica Química, LDA
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 34 | — | 2026-10-27 |
| GILEAD SCIENCES, LDA | 29 | — | 2026-10-13 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 23 | €1,569,649 | 2026-10-20 |
| JANSSEN-CILAG FARMACEUTICA LDA | 19 | €371,730 | 2026-10-13 |
| NOVARTIS FARMA - PROD.FARM SA | 19 | — | 2026-10-20 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
POLATUZUMAB VEDOTINA [140 MG PÓ CONC SOL INJ FRS]